{
    "2020-01-21": [
        [
            {
                "time": "2019-03-27",
                "original_text": "Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Approval",
                        "MS Drug",
                        "Mayzent",
                        "Europe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-14",
                "original_text": "Puma Biotech's (PBYI) Breast Cancer Drug Nerlynx Aids Growth",
                "features": {
                    "keywords": [
                        "Puma Biotech",
                        "Breast Cancer",
                        "Drug Nerlynx",
                        "Growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe",
                "features": {
                    "keywords": [
                        "Jazz",
                        "New Sleep Drug",
                        "Sunosi",
                        "Approval",
                        "Europe"
                    ],
                    "sentiment_score": 0.88,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}